Insulin products marketed in the United States
| InsuIin (Brand) |
| Rapid-acting Insulin aspart (NovoLog) Insulin lispro (Humalog) Insulin glulisine (Apidra) |
| Short-acting Regular insulin (Humulin R, Novolin R/ReliOn R) |
| Intermediate, basal NPH insulin (Humulin N, Novolin N/ReliOn N) |
| Basal analogues Insulin glargine U-100 (Lantus, Basaglar) Insulin detemir (Levemir) |
| Longer-acting basal analogues Insulin glargine U-300 (Toujeo) Insulin degludec (Tresiba) |
| Premixed 75% Insulin lispro protamine/25% insulin lispro (Humalog mix 75/25) 50% Insulin lispro protamine/50% insulin lispro (Humalog mix 50/50) 70% Insulin lispro protamine/30% insulin aspart (Novolog mix 70/30) 70% NPH insulin/30% regular insulin (Humulin, Novolin/ ReliOn) 70% Insulin degludec/30% insulin aspart (Ryzodeg 70/30) |
| Inhaled Technosphere insulin oral-inhalation system (Afrezza) |
NPH = neutral protamine Hagedorn.